Fairhaven Capital Partners Investor
Two former partners of Cambridge venture firm Fairhaven Capital have spun out a new firm of their own, focused on investing in startups that use artificial intelligence. Glasswing Ventures will be...
Technology:
Drug Discovery
Headquarters:
Cambridge, Massachusetts, United States
Acquisitions Number:
NA
Funding Status:
N/A
Investment Stage:
Early Stage Venture, Late Stage Venture, Seed
Founded Date:
2001-01-01
Number Of Exists:
20
Investors Number:
69
Estimated Revenue:
$1M to $10M
Zip:
NA
Employee Number:
1-10
Industry:
Finance & Banking
Investor Type:
Technology - oriented Investor with Venture Investment Focus